September 2020

 

Bellagio

Las Vegas, Nevada

Independent Symposia

Thank you to the attendees, faculty, sponsors, and supporters of the Annual Perspectives in Rheumatic Diseases Conference for making the conference a tremendous success!  We hope to see you again in 2020. SIGN UP for email updates to keep informed of program developments for our upcoming conference as they become available.

SIGN UP FOR UPDATES


 

CME/CE credit is not provided for these sessions, unless otherwise noted

 

Friday, September 20, 2019

7:00 – 8:00 AM

Beyond the Joints: The Story of IL-6 and Rheumatoid Arthritis
Faculty: George A. Karpouzas, MD 
Sponsored by: Sanofi Genzyme Regeneron

9:50 – 10:50 AM

CME is provided for this session (Additional 1.0 AMA PRA Category 1 Credit™)
Clinical Issues in Rheumatoid Arthritis: The Evolving Role of JAK Inhibitors
Faculty: Robin K Dore, MD and Maria Greenwald, MD, FACR
This activity is jointly provided by Global Education Group and Integritas Communications and supported by an educational grant from Gilead Sciences, Inc.

12:45 – 1:30 PM

Exploring Clinical Data for a New RA Treatment
Faculty: John Tesser, MD, FACP, FACR
Sponsored by: AbbVie 

6:30 – 7:15 PM

A Multicenter Study Assessing New Data for Patients With Persistently Active Rheumatoid Arthritis
Faculty: Sanjay Chabra, DO
Sponsored by: Mallinckrodt Pharmaceuticals 

   

Saturday, September 21, 2019

7:10 – 7:55 AM

The First and Only Therapy Approved for Adult Patients With Oral Ulcers Associated With Behçet’s Disease
Faculty: Robert Hozman, MD 
Sponsored by: Celgene

1:00 – 1:45 PM

CORE: Clinical Overview of Rheumatology Evidence: COSENTYX® (secukinumab) for the Treatment of Patients With AS, PsA, and PsO         
Faculty: Alvin Wells, MD, PhD
Sponsored by: Novartis Pharmaceuticals 

 

Follow Us

Jointly Provided By

In Association With